GSK2982772
Faahfaahinta Alaabta
Tags Product
Cabbirka Xidhmada | Helitaanka | Qiimaha (USD) |
100mg | In Stock | 500 |
500mg | In Stock | 800 |
1g | In Stock | 1200 |
Cabiro badan | Hel Xigasho | Hel Xigasho |
Magaca Kiimikada:
(S)-5-Benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b]-[1,4] oxazepin-3-yl)-4H-1,2, 4-triazole-3-carboxamide
Koodhka dhoola cadeynta:
O=C(C1=NN=C(CC2=CC=CC=C2)N1)N[C@@H]3C(N(C)C4=CC=CC=C4OC3)=O
Koodhka InChi:
InChi=1S/C20H19N5O3/c1-25-15-9-5-6-10-16(15)28-12-14(20(25)27)21-19(26)18-22-17(2) 3-24-18)11-13-7-3-2-4-8-13/h2-10,14H,11-12H2,1H3,(H,21,26)(H,22,23,24) /t14-/m0/s1
Furaha InChi:
LYPAFUINURXJSG-AWEZNQCLSA-N
Ereyga muhiimka ah:
GSK-2982772, GSK 2982772, GSK2982772, 1622848-92-3
Xalka:Ku milmay DMSO
Kaydinta:0 - 4°C muddo gaaban (maalmo ilaa toddobaadyo), ama -20°C muddo dheer (bilo).
Sharaxaad:
GSK2982772 waa soo-dhoweeye awood leh oo la xushay Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate for the Treatment of Inflammatory Diseases. GSK2982772 waa, hadda ku jira marxaladda 2a daraasadaha kiliinikada ee cudurka psoriasis, rheumatoid arthritis-ka, iyo colitis boogaha. GSK2982772 waxay si xoog leh ugu xidhan tahay RIP1 oo leh gaar gaar ah kinase waxayna leedahay hawl aad u wanaagsan oo lagu joojinayo jawaabaha gacanta ee TNF-ku-tiirsanaanta badan. RIP1 waxay u soo baxday kinase muhiim ah oo kor u kaca oo lagu muujiyay in lagu xakameeyo bararka iyada oo loo marayo labadaba labadaba iyo hawlaha gaarka ah ee kinase.
Ujeedka: RIP1